Literature DB >> 33477983

Radiological Findings in Multidetector Computed Tomography (MDCT) of Hereditary and Sporadic Pulmonary Veno-Occlusive Disease: Certainties and Uncertainties.

Marta Pérez Núñez1,2, Sergio Alonso Charterina1,2, Carmen Pérez-Olivares2,3,4,5, Yolanda Revilla Ostolaza1,2, Rafael Morales Ruiz1,2, Ana Belén Enguita Valls2,6, Jair Antonio Tenorio7,8,9, Natalia Gallego Zazo7,8,9, Alicia De Pablo Gafas2,10, Pablo Lapunzina7,8,9, Adriana Rodríguez Chaverri2,3, Pilar Escribano Subías2,3,4,5.   

Abstract

Pulmonary veno-occlusive disease (PVOD) is a very infrequent form of pulmonary arterial hypertension with an aggressive clinical course, poor response to specific vasodilator treatment, and low survival. Confirming a definitive diagnosis is essential to guide treatment and assess lung transplantation. However, in the absence of histological or genetic confirmation, the diagnosis is complex, requiring a clinical suspicion. Multidetector computed tomography (MDCT) is an essential part of the non-invasive diagnostic tools of PVOD. We retrospectively reviewed the MDCT findings from a consecutive series of 25 patients diagnosed with PVOD, 9 with the sporadic form and 16 with the hereditary form of the disease. The presence and extent of typical findings of the diagnostic triad were assessed in all patients (ground glass parenchymal involvement, septal lines, and lymphadenopathy). In our series, 92% of patients showed at least two of the radiological findings described as typical of the disease. All patients presented at least one typical radiological characteristic. The incidence of radiological findings considered typical is very high, however was not associated with greater hemodynamic severity nor to the development of acute lung edema. No significant differences were found between the two groups. A poorly expressive MDCT does not exclude the disease.

Entities:  

Keywords:  multidetector computed tomography (MDCT); pulmonary hypertension; pulmonary veno-occlusive disease

Year:  2021        PMID: 33477983      PMCID: PMC7835925          DOI: 10.3390/diagnostics11010141

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  20 in total

1.  Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.

Authors:  David Montani; Barbara Girerd; Xavier Jaïs; Marilyne Levy; David Amar; Laurent Savale; Peter Dorfmüller; Andrei Seferian; Edmund M Lau; Mélanie Eyries; Jérôme Le Pavec; Florence Parent; Damien Bonnet; Florent Soubrier; Elie Fadel; Olivier Sitbon; Gérald Simonneau; Marc Humbert
Journal:  Lancet Respir Med       Date:  2017-01-11       Impact factor: 30.700

2.  Fleischner Society: glossary of terms for thoracic imaging.

Authors:  David M Hansell; Alexander A Bankier; Heber MacMahon; Theresa C McLoud; Nestor L Müller; Jacques Remy
Journal:  Radiology       Date:  2008-01-14       Impact factor: 11.105

3.  High-resolution CT of the chest in four patients with pulmonary capillary hemangiomatosis or pulmonary venoocclusive disease.

Authors:  B Dufour; S Maître; M Humbert; F Capron; G Simonneau; D Musset
Journal:  AJR Am J Roentgenol       Date:  1998-11       Impact factor: 3.959

Review 4.  Pulmonary veno-occlusive disease: pathogenesis, risk factors, clinical features and diagnostic algorithm - state of the art.

Authors:  Monika Szturmowicz; Aneta Kacprzak; Małgorzata Szołkowska; Barbara Burakowska; Ewa Szczepulska; Jan Kuś
Journal:  Adv Respir Med       Date:  2018

5.  Survival in pulmonary hypertension in Spain: insights from the Spanish registry.

Authors:  Pilar Escribano-Subias; Isabel Blanco; Manuel López-Meseguer; Carmen Jimenez Lopez-Guarch; Antonio Roman; Pilar Morales; María Jesús Castillo-Palma; Javier Segovia; Miguel A Gómez-Sanchez; Joan Albert Barberà
Journal:  Eur Respir J       Date:  2012-02-23       Impact factor: 16.671

6.  Variable Expressivity of a Founder Mutation in the EIF2AK4 Gene in Hereditary Pulmonary Veno-occlusive Disease and Its Impact on Survival.

Authors:  Paula Navas Tejedor; Julián Palomino Doza; Jair Antonio Tenorio Castaño; Ana Belén Enguita Valls; José Julián Rodríguez Reguero; Amaya Martínez Meñaca; Ignacio Hernández González; Héctor Bueno Zamora; Pablo Daniel Lapunzina Badía; Pilar Escribano Subías
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2017-07-09

7.  EIF2AK4 Mutations in Patients Diagnosed With Pulmonary Arterial Hypertension.

Authors:  D Hunter Best; Kelli L Sumner; Benjamin P Smith; Kristy Damjanovich-Colmenares; Ikue Nakayama; Lynette M Brown; Youna Ha; Eleri Paul; Ashley Morris; Mohamed A Jama; Mark W Dodson; Pinar Bayrak-Toydemir; C Gregory Elliott
Journal:  Chest       Date:  2016-11-22       Impact factor: 9.410

8.  A founder EIF2AK4 mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies.

Authors:  J Tenorio; P Navas; E Barrios; L Fernández; J Nevado; C A Quezada; M López-Meseguer; P Arias; R Mena; J L Lobo; C Alvarez; K Heath; P Escribano-Subías; P Lapunzina
Journal:  Clin Genet       Date:  2015-01-07       Impact factor: 4.438

9.  Pulmonary venoocclusive disease: CT findings in eight patients.

Authors:  S J Swensen; J H Tashjian; J L Myers; C E Engeler; E F Patz; W D Edwards; W W Douglas
Journal:  AJR Am J Roentgenol       Date:  1996-10       Impact factor: 3.959

10.  Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension.

Authors:  Charaka Hadinnapola; Marta Bleda; Matthias Haimel; Nicholas Screaton; Andrew Swift; Peter Dorfmüller; Stephen D Preston; Mark Southwood; Jules Hernandez-Sanchez; Jennifer Martin; Carmen Treacy; Katherine Yates; Harm Bogaard; Colin Church; Gerry Coghlan; Robin Condliffe; Paul A Corris; Simon Gibbs; Barbara Girerd; Simon Holden; Marc Humbert; David G Kiely; Allan Lawrie; Rajiv Machado; Robert MacKenzie Ross; Shahin Moledina; David Montani; Michael Newnham; Andrew Peacock; Joanna Pepke-Zaba; Paula Rayner-Matthews; Olga Shamardina; Florent Soubrier; Laura Southgate; Jay Suntharalingam; Mark Toshner; Richard Trembath; Anton Vonk Noordegraaf; Martin R Wilkins; Stephen J Wort; John Wharton; Stefan Gräf; Nicholas W Morrell
Journal:  Circulation       Date:  2017-09-28       Impact factor: 29.690

View more
  3 in total

Review 1.  Description of Two New Cases of AQP1 Related Pulmonary Arterial Hypertension and Review of the Literature.

Authors:  Natalia Gallego-Zazo; Alejandro Cruz-Utrilla; María Jesús Del Cerro; Nuria Ochoa Parra; Julián Nevado Blanco; Pedro Arias; Pablo Lapunzina; Pilar Escribano-Subias; Jair Tenorio-Castaño
Journal:  Genes (Basel)       Date:  2022-05-22       Impact factor: 4.141

2.  Dual-Energy CT Pulmonary Angiography for the Assessment of Surgical Accessibility in Patients with Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Matthias Eberhard; Micheal McInnis; Marc de Perrot; Mona Lichtblau; Silvia Ulrich; Ilhan Inci; Isabelle Opitz; Thomas Frauenfelder
Journal:  Diagnostics (Basel)       Date:  2022-01-18

3.  Predictive value of chest HRCT for survival in idiopathic pulmonary arterial hypertension.

Authors:  Aneta Kacprzak; Barbara Burakowska; Marcin Kurzyna; Anna Fijałkowska; Michał Florczyk; Maria Wieteska-Miłek; Szymon Darocha; Adam Torbicki; Monika Szturmowicz
Journal:  Respir Res       Date:  2021-11-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.